Rekha
Faculty Name: Mrs.Rekha.S
Designation : Assistant Professor
Experience in Years:
  1. 6.5 yrs (Before PG)
  2. 10yrs (After PG)
Area of Interest:
  1. Development of Novel Chemical entities as future possible Anti-diabetic agents.
  2. Phytochemical and Pharmacological Investigations of medicinal plants.
  3. CADD & QSAR
Email Id:
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Slider

View More

INTERNATIONAL/ NATIONAL JOURNAL PUBLICATIONS

  1. “Comparitive study and antimicrobial activities of alcoholic and aqueous extracts of eucalyptus globules” World journal of pharmacy and pharmaceutical sciences.2016:5(9); 1678-1684.
  2. “Antioxidant activity of 5-(substituted benzylidene) thiazolidinedione derivatives” World Journal of Pharmaceutical research, 2017:6(9); 878-92.
  3. “Novel Substituted thiazolidinedione derivatives as anti-diabetic agents” European journal of pharmaceutical and medical research, 2017, 4 (9), 643-652.
  4. “Insilico Proportional Molecular Docking Study and Analysis of Insulinotropic Activity of TZD Derivatives by PPARγ Activation” Journal of Pharmaceutical science and research, 2017, Vol. 9(10), 1799-1808.
  5. “Comparitive antioxidant activity of three herbal extracts” World Journal of Pharmaceutical research, 2017:6(2); 1234-40.
  6. “Alcoholic and Aqueous Extract of Eucaluyptus Globules Posses Antimicrobial Activity and Antifungal Property Confined only to Alcoholic Extract” Research & reviews: a journal of pharmaceutical science.2016: 7(3); 26-29.
  7. “Anti fertility effect of ziziphus jujumba mill”. World journal of pharmaceutical sciences. 2014: 3(3); 1363-1370.
  8. “Antioxidant and antibacterial activities of thiazolidinedione derivatives” International Journal of Pharmaceutical science and Research 2014: 53(6); 421-428.
  9. “Antihelicobacter pylori activity of substituted benzothiazoles: In vitro study”. Asian journal of pharmaceutical and clinical reacearch. 2014: 7(1); 201-204.
  10. “Synthesis and in vitro antitumor evaluation of novel benzimidazole-schiff’s base conjugates” Contemporary investigations and observations in pharmacy 2013:2(3); 72-78.
  11. “Synthesis and Characterization of novel Benzimidazole derivatives and evaluation of their Anti bacterial activities”. International Journal of Pharmaceutical Sciences Letters 2013: Vol. 3 (1); 173-176.
  12. “Synthesis, characterization and evaluation of In-Vitro and In-Vivo anti inflammatory activity of novel benzimidazole derivatives” International journal of pharmacy & life sciences 2013:4(7): 147-152.
  13. “Synthesis, characterization and evaluation of microbial activity of some heterocyclic compounds containing benzothiazole moieties” Journal of Drug Discovery and Therapeutics 2013: 1 (5); 29-36.
  14. “Comparitive study of memory enhancing property of modafinil and cissampelos pariera in mice” Journal of Drug Discovery and Therapeutics 2013:1(5); 26-28.
  15. “Synthesis and evaluation of novel thiazolidinediones for anti diabetic activity” International Journal of Pharmacy & Pharmaceutical Sciences;2011: Vol. 3;113
  16. “Synthesis and evaluation of novel thiazolidinediones for anti inflammatory activity” International Research Journal of Pharmacy, 2011:2(9); 81-84.
  17. “Isolation, Identification and Characterization of endophytic fungi from moringa oleifera for the anti microbial activities” World journal of pharmacy and pharmaceutical sciences.2018; 8(1): 1181-1189.
  18. “Bacterial endophytes from moringa oleifera plant for the anti oxidant activity” International research journal of pharmacy.2019: 10(7): 127-30

POSTER PRESENTATION:

  1. Presented a poster presentation on “Inhibitors of α- amylase by 5- (substituted benzylidene) thiazolidine-4-one-a possibility to treat diabetes mellitus type ii” at KLE College of Pharmacy, Belgaum on 26 and 27 October, 2018.
  2. Presented a poster presentation on “Novel substituted thiazolidine-4-one derivatives as Anti-diabetic agents” at T John College of Pharmacy, Bengaluru on 23 March, 2018.

CONFERENCS ATTENDED:

  1. Participated in a Workshop with the theme “Molecular modelling” at at KLE College of Pharmacy, Belgaum on 15 October, 2018.
  2. Participated in a national seminar with the theme “New trends in drug metabolism & pharmacokinetics in preclinical research” Siddartha college of pharmaceutical sciences,Vijaywada on 24th-25th Apirl, 2019.

AWARD RECEIVED:

  1. Best poster award “Inhibitors of α- amylase by 5- (substituted benzylidene) thiazolidine-4-one-a possibility to treat diabetes mellitus type II” at KLE College of Pharmacy, Belgaum on 26 and 27 October, 2018.

GUEST TALK ORGANISED:

  1. “Carrer oppurtunities in Pharmaceutical industries” on 2/2/19 by Mr. Vidya sagar kannan, senior manager, Novartis and Mrs. Thawamani kotteswaran, HR manager, Novartis, Bangalore.
  2. “Recent trends in Pharma industries” on 6/8/2019 by Dr. Basavaraj K nanjwad, Principal Scientist, Trroyn life sciences, Bangalore.

MEMBERSHIP:

    Life time membership from Society of Pharmaceutical sciences & research ( SPER)

dsu

 

The Main Campus:

  • Campus 1: Dayananda Sagar University
  • 6th Floor, Dental Block, Shavige Malleshwara Hills, Kumaraswamy layout,
    Bangalore-560 111, India.
  • Schools at Campus 1:
    School of Commerce & Management Studies,
    Basic & Applied Sciences,
  • Health Sciences, Arts & Humanities.
  • Office of Admissions: +91 80 4646 1800

  • Campus 3: Dayananda Sagar University
  • Innovation Campus, Hosur Main Road, Kudlu Gate, Bangalore-560 114, Karnataka, India.
  • Schools at Campus 3:
    School of Engineering (B.Tech. | M.Tech.| BCA),
    Department of MBA ( MBA )
  • Office of Registrar: +91 80 4909 2910 / 11
    Office of Dean (School of Engineering): +91 80 4909 2986 / 32 / 33
    Dean - MBA: +91 80 4909 2931
    Research Cell: +91 80 4909 2912 / +91 97390 17462
    Office of Admissions: +91 80 4909 2924 / 25
    Fax : +91 80 4220 1997
  • E-mail: [email protected] / [email protected] / [email protected]